Top Abstract Purchase Related
Home
>
Node
>
Subnode

Prophylactic and curative treatment of migraine with calcium antagonists

Amery, W.K.

Drug Design and Delivery 4(3): 197-203

1989

ISSN/ISBN: 0884-2884
PMID: 2490274
Document Number: 342765
The present review discusses the available clinical information dealing with the treatment of migraine with calcium entry blocking agents. The data on prophylactic therapy are limited to 3 compounds, of which flunarizine is the most extensively studied and the only substance whose activity is well established. Clinical experience with these agents in the acute treatment of migraine attacks is still very limited.

Document emailed within 1 workday
Secure & encrypted payments

Krymchantowski, A.V.; Moreira Filho, P.F. 1999: Update on migraine prophylactic treatment Arquivos de Neuro-Psiquiatria 57(2b): 513-519
Visudtibhan, A.; Lusawat, A.; Chiemchanya, S.; Visudhiphan, P. 2004: Flunarizine for prophylactic treatment of childhood migraine Journal of the Medical Association of Thailand 87(12): 1466-1470
Schoenberger, J.A. 1988: Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics Angiology 39(1 Part 2): 87-93
Gelmers, H.J. 1988: The significance of calcium in ischemic cell damage and the role of calcium antagonists in the treatment of acute cerebral ischemia Nederlands Tijdschrift Voor Geneeskunde 132(49): 2230-2232
Ryan, R.E.; Ryan, R.E.; Sudilovsky, A. 1982: Nadolol and placebo comparison study in the prophylactic treatment of migraine Panminerva Medica 24(2): 89-94
Yagil, Y.; Yagil, C. 1983: Calcium antagonists in the treatment of hypertension Harefuah 104(7): 313-314
Rosenthal, J.; Völger, K.D. 1991: The role of calcium antagonists in the treatment of hypertension Der Internist 32(12): 674-689
Klaus, D. 1992: The role of calcium antagonists in the treatment of hypertension Journal of Cardiovascular Pharmacology 20(Suppl 6): S5-14
Krzesinski, J.M.; Rorive, G.L. 1988: Calcium antagonists in the treatment of arterial hypertension Revue Medicale de Liege 43(9): 310-320
Shi, C.Z.; Li, X.M.; Liu, Y.; Zhang, J.T. 1990: Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists Yao Xue Xue Bao 25(3): 223-226
Lanteri-Minet, M.; Alchaar, H.; Besson, G.; Bille-Turc, F.; Bouillat, J.; Brudon, F.; Donnet, A.; Galletti, P.; Maitre, M.; Moene, Y.; Rambaud, G.; Rostini, C.; Valance, J.; Gastaut, J.L. 2000: Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø Revue Neurologique (Paris) 156(12): 1106-1112
Zharov, E.I.; Vertkin, A.L.; Prokhorovich, E.A.; Adib, B.M. 1987: Calcium antagonists in the treatment of congestive heart failure Klinicheskaia Meditsina 65(2): 20-27
Bosson, R.; Loizeau, E. 1987: Treatment of disorders of esophageal motility with calcium antagonists Revue Medicale de la Suisse Romande 107(7): 553-558
Rafflenbeul, W. 1984: Calcium antagonists in the treatment of coronary heart disease Fortschritte der Medizin 102(27-28): 718-721
Lederballe Pedersen, O. 1983: The experimental use of calcium antagonists in the treatment of arterial hypertension Postgraduate Medical Journal 59(Suppl 2): 84-90
Ol'binskaia, L.I.; Vartanova, O.A. 1984: Calcium antagonists in the treatment of ischemic heart disease Kardiologiia 24(2): 10-13
Pereirinha, A.; Amaro, M.J.; Lopes, M.G.; de Pádua, F. 1993: Calcium antagonists in the treatment of congestive heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 12(Suppl 4): 47-51; 9
Andreeva, T.N. 1990: Foridone and other calcium antagonists in the treatment of essential hypertension Cor et Vasa 32(1): 45-55
Pradalier, A.; Guérard des Lauriers, A.; Scheck, F.; Peraudeau, P.; Lacoste, J.P.; Cajfinger, F. 1995: Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks Pathologie-Biologie 43(9): 806-813
Mayerhofer, S. 1986: Mechanism of action of calcium antagonists in the treatment of vascular diseases Wiener Medizinische Wochenschrift 136(21-22): 591-594